UNIVERCELLS

The recent transmission of H5N1 bird flu to a pig in the Unites States is a wake-up call.    It highlights the virus’ ability to spread across species, and the importance of vaccinating against #AvianInfluenza. If bird flu continues to spread among animals, the impact on food production and security could be severe. There’s also a risk that pigs, which can act as “mixing vessels” for viruses, may facilitate gene exchange between avian and human viruses, potentially heightening the risk of human infection.   Vaccination, alongside vigilant surveillance, is essential. By protecting poultry and other animals, we can reduce the risk of cross-species transmission, safeguarding both animal and human health. These proactive measures also help secure global food supply chains, supporting food security worldwide.   At UNIVERCELLS, we're advancing biotech for human and animal health. Our RNA Design-to-Delivery Solutions for livestock prophylactic vaccines enable scalable, high-yield production and integrate novel delivery systems to foster protective immunity across various diseases and species, allowing rapid responses to outbreaks and new variants.   For more background information, you can find a link to the news article in the comments.   #BiotechInnovation #OneHealth 

We’re feeling incredibly inspired here at #BioEurope2024! It’s energizing to connect with biotech and pharma leaders, exchange insights on the future of healthcare, and explore how we can break down barriers to make innovative treatments more accessible to people everywhere. From discussions on oncology, vaccines, and solutions for both human and animal health, to forging potential new collaborations - it’s truly an impactful experience all around! If you’re attending and we haven’t met yet, come say hello. We’d love to connect and discuss how we can work together to transform healthcare globally. #BiotechInnovation #PartnershipsForHealth 

Hala Audi, our Chief Alliance Officer, joined the Platform Technologies Workshop as a panelist at the World Vaccine Congress Europe on Monday, October 28. Thank you to everyone who attended and engaged in the discussion on the expansion of RNA “everything and everywhere.” We’re grateful for the chance to connect and exchange insights on the future of vaccine technology with such a thoughtful audience. We look forward to continuing these essential conversations together. #WVCEU #vaccinetechnology #innovation UNIVERCELLS

We’re excited to attend #BioEurope2024 next week, the premier biotech and pharma collaboration event. At UNIVERCELLS our purpose is clear: to transform how biotech drugs are made so everyone, everywhere, can get them. We’re eager to connect with stakeholders who share our vision of making healthcare more accessible – so don’t hesitate to connect with us in Stockholm and see how we can collaborate to make a global impact! #BiotechInnovation #PartnershipsForHealth Laurie Clotilde,

UNIVERCELLS is excited to participate in The World Vaccine Congress Europe 2024 next week! We’ll be meeting with global experts and innovators to discuss the latest in vaccine development and manufacturing. From improving vaccine accessibility to exploring cutting-edge technologies like mRNA and beyond, we aim to transform how biotech drugs are made, helping to make life-saving treatments more accessible and affordable to people, wherever they are. We look forward to connecting with leaders and partners as we continue pushing the boundaries of biotech innovation! #WorldVaccineCongress #BiotechInnovation #AccessToInnovation Maria Davila-Saignol

As bird flu continues its global spread, impacting both wild birds and poultry, it’s time to rethink how we manage this threat. The virus is deeply rooted in wildlife, and the poultry industry faces constant risk. A promising solution? Avian influenza vaccination. Wider vaccination can help sustain poultry production, improve animal welfare, and limit economic damage. It’s also a crucial step to protect wildlife and prevent human infections. At UNIVERCELLS, we’re driving advancements in biotechnologies, such as RNA vaccines, which can help transform our approach to avian influenza. Next week, our team will join global experts at the #HPAI2024 Conference to address this critical issue. We hope to see you there! Together, we can protect animals and humans by harnessing the latest in biotech to stay ahead of the curve. #AvianInfluenza #BiotechInnovation

Cancer touches us all. Whether it’s someone we love or a personal battle, its impact is an everyday reality. With nearly 20 million new cases diagnosed globally each year, faster, more affordable access to treatment is critical. New cancer therapies offer hope thanks to scientific breakthroughs, but high costs and long development times leave many patients waiting. At UNIVERCELLS we believe no one should have to wait for life-saving treatments. We’re developing technologies to accelerate production, make them more affordable, and get therapies to patients more quickly through localized manufacturing. Cancer shouldn’t win because of time or cost. We're transforming how biotech drugs are made to ensure life-saving treatments reach those who need them most. Find out more about what we do here: https://lnkd.in/eNy4b7sc #BiotechInnovation #Oncology #AcessToTherapies

Exciting news from Univercells! Our CTO and co-founder, Jose Castillo, has been inducted into the Royal Academy of Belgium (Académie royale des Sciences, des Lettres et des Beaux-Arts de Belgique) as a member of the class of Technology and Society. This prestigious recognition honors José's impactful contributions to biotechnology and his innovative efforts to make essential medicines more accessible to people worldwide. We are proud to see José's visionary leadership recognized at such a high level. Congratulations, José! ▶ More info: https://lnkd.in/eQqVUEAZ #BiotechInnovation #Leadership #PurposeWithImpact

Last week, our Univercells colleagues - Hilde Vrancken, Víctor Martínez Poloo, and Rodrigue Viérin Bornemann – were thrilled to participate in the very first FAO Global Conference on Animal Health Innovation, Reference Centres and Vaccines. At UNIVERCELLS, our innovative technology platforms don’t just benefit humans - we’re also applying them to protect animals. Vaccinating livestock can help ensure a safe and stable food supply while preventing disease outbreaks that can impact human health. Our technology allows us to develop new vaccines for animal health as soon as a threat emerges. By advancing both animal and human health, Univercells is working to create a healthier, more sustainable future. This conference gave us a unique opportunity to learn from global leaders and explore how cutting-edge innovation can propel us toward this shared goal. Many thanks to Thanawat Tiensin, Samia Metwally, and Xavier Roche for hosting us!

Today on #WorldRabiesDay, we join global health leaders in breaking boundaries to end rabies - a disease that’s 100% preventable yet still claims the lives of nearly 60,000 people globally each year, almost half of which are children. Just as rabies doesn’t recognize borders, neither should access to life-saving vaccines. At UNIVERCELLS, we work to find solutions that enable local production and make rabies vaccines more affordable and accessible to the communities that need them most. We focus on breaking barriers in drug development - accelerating timelines, reducing costs, and revolutionizing vaccine production to ensure global accessibility. Driven by collaboration and innovation, we are advancing technologies to create a future where rabies is no longer a threat. Let’s #BreakRabiesBoundaries together and help meet the common goal of the World Health Organization, FAO, World Organisation for Animal Health, and Global Alliance for Rabies Control of zero rabies deaths by 2030. #BiotechInnovation